We have reported the diversity of polymorphism frequencies for the CYP2D6, CYP3A5, CYP2C8, and IL-10 genes in breast cancer patients from Mexico and Spain and classified them by metabolic activity for chemotherapy but no specific function has been described for these polimorphisms [44]. This evidence concerns the gene CYP3A5 and breast carcinoma.